Clinical/scientific notes

Neurology

Volumn 81, Issue 4, 2013, Pages 395-397

  Bittner, Stefan ^a   Simon, Ole J ^a   Göbel, Kerstin ^a   Bien, Christian G ^b   Meuth, Sven G ^a   Wiendl, Heinz ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b EPILEPSY CENTER BETHEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BOTULINUM TOXIN; CD4 ANTIGEN; CD8 ANTIGEN; DEXAMETHASONE; ETIRACETAM; IMMUNOGLOBULIN; NATALIZUMAB; PREGABALIN; RITUXIMAB; ZONISAMIDE; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

BRAIN CORTEX ATROPHY; CASE REPORT; CD4 CD8 RATIO; CHILD; CLONIC SEIZURE; DISEASE COURSE; DRUG TREATMENT FAILURE; EPILEPTIC STATE; FEMALE; HEMIPARESIS; HUMAN; LANGUAGE DISABILITY; LEFT HEMISPHERE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; RASMUSSEN SYNDROME; SCHOOL CHILD; SEIZURE; SHORT SURVEY; TREATMENT DURATION; TREATMENT RESPONSE; WADA TEST; ADULT; ARTICLE; ENCEPHALITIS;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ENCEPHALITIS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS;

EID: 84881272423     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829c5ceb     Document Type: Short Survey

References (7)

1. Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005;128:454-471.
2. Bien CG, Tiemeier H, Sassen R, et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia 2013;54:543-550.
3. Thilo B, Stingele R, Knudsen K, et al. A case of Rasmussen encephalitis treated with rituximab. Nat Rev Neurol 2009; 5:458-462.
4. Takahashi Y, Mine J, Kubota Y, Yamazaki E, Fujiwara T. A substantial number of Rasmussen syndrome patients have increased IgG, CD41 T cells, TNFalpha, and Granzyme B in CSF. Epilepsia 2009;50:1419-1431.
5. Stuve O, Marra CM, Bar-Or A, et al. Altered CD41/CD81 T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 2006;63: 1383-1387.
6. Fabene PF, Navarro Mora G, Martinello M, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008;14:1377-1383.
7. Sotgiu S, Murrighile MR, Constantin G. Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis: case report. BMC Neurol 2010;10:84.